{"id":1367,"createDateTime":"2026-08-12T04:10:20.838Z","archiveDateTime":"2027-12-31T00:00:00.000Z","name":"Diagnosing osteoporosis and the latest treatment pathways","image":"4086d7dafc37fcd4356cd14c54e79767426d7f838825d6adc9e4684a","imageThumbnail":"e92410f1c9fa8ea1dd05b02c7b9594a42922d0be0c0ec815fee88113","about":"Osteoporotic fractures can lead to loss of independence, depression and increased mortality risk. Osteoporosis remains underdiagnosed and undertreated. This activity provides a quick overview on the diagnostic criteria for osteoporosis and the criteria for assessing fracture risk and selecting the appropriate long-term treatment pathways to optimise patient care.\n\nThis activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours. \n\n# Learning Outcomes\n1. Outline the current diagnostic criteria and treatment pathways for osteoporosis.\n2. Critically reflect on recent interactions with patients to optimise fracture risk assessment and treatment selection.\n3. Apply guideline-aligned approaches to diagnosing osteoporosis and selecting appropriate treatment pathways.\n\n# Provider\nThe Provider of this activity is [Praxhub](https://app.praxhub.com/orgs/1). Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com. ","type":"video","summaryViewCount":41,"startDateTime":null,"durationSecs":855,"organisation":{"id":101,"name":"Arrotex","logoImage":"343d2282723763f021df947917df828894bcf90cd0942a7b794bdcd8","logoImageThumbnail":"4cb9c205c6d9ce99135b8445d977a6b5da5a4f07cbd1b9811fbd93f2","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":0,"likeCount":0,"presenters":[{"id":59011,"specialty":{"id":55,"name":"Endocrinology"},"name":"Prof Peter Ebeling","title":null,"profileImage":"130014b42b62e293b3198b082e23b913e49ce03d6287f0d721a2b15a","profileImageThumbnail":"ea7f67280acb2346d48aac22862cc31b66f5b5d598580ee4b15ae9c8"}],"relatedEducation":[{"id":1363,"name":"Oral Contraception: From Evidence to Practice ","image":"42d0a4f8a46f82c540c4c00afded1b3fc29d0ff0c0c808504d3cc458","imageThumbnail":"4b3f571a5a638bcdc9c3d417204de62c4244bd5b7e63d21fe20d6a61","type":"zoom-webinar","startDateTime":"2026-09-09T09:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1373,"name":"Hormonal Acne Management for General Practice","image":"8980d52fa2537eff660b08b44f79752a006b26b23d223206ddf22a8a","imageThumbnail":"bb0b3a191abc66b9631de005b87931e2765d514fc7d71ae5d2fd8f57","type":"zoom-webinar","startDateTime":"2026-10-08T08:30:00.000Z","durationSecs":5400,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1371,"name":"Fracture risk perception and medication adherence","image":"8a32746a58f9ae41f671a7e9c947bb28f50471654044468665d3c5e7","imageThumbnail":"0563278e7f8893527677202c291cc4fc492c520ca53ccc1b743c91e6","type":"video","startDateTime":null,"durationSecs":454,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1370,"name":"Pharmacological considerations for long-term antiresorptive drug (ARD) therapy ","image":"486aaf82a6cd773abd54f88e7e0df641b671075061b3281e755c87af","imageThumbnail":"bf7fe9ca785b08607ae90187607860a533437433ba322ada091c4858","type":"video","startDateTime":null,"durationSecs":677,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1369,"name":"Medication-Related Osteonecrosis of the Jaw (MRONJ) and Osteoporosis","image":"8c4c071a6aaf8b1a9bcb1fd512eb112139c29ab8a970878215410ac9","imageThumbnail":"c5c976a9d9686a6b4364971a7987bb1e88ebae607f5ffcfb4dc3ea69","type":"video","startDateTime":null,"durationSecs":475,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1368,"name":"Osteoporotic Fracture vs Atypical Femoral Fracture (AFF)","image":"e47038a006cf6a26f6fcc26839a6a41a501306708d30a1df05682b1b","imageThumbnail":"365e97ca3567b7d1accf0e2f7a837e17c9f3e7b999384095779d33c8","type":"video","startDateTime":null,"durationSecs":370,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}}]}